LEADER 03849nam  2201213z- 450 
001 9910637795003321
005 20231214133404.0
010   $a3-0365-5683-4
035   $a(CKB)5470000001631586
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/94506
035   $a(EXLCZ)995470000001631586
100   $a20202212d2022      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPolymers Enhancing Bioavailability in Drug Delivery
210   $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022
215   $a1 electronic resource (260 p.)
311   $a3-0365-5684-2 
330   $aThis Special Issue provides an update on the state of the art and current trends in polymeric drug-delivery systems specifically designed for improving drug bioavailability. The multiple contributions received further strengthen the role of polymers in modern drug delivery and targeting, illustrating the different approaches possible and unveiling what the future may bring.
606   $aMedicine$2bicssc
606   $aPharmaceutical industries$2bicssc
610   $acystic fibrosis
610   $aPseudomonas aeruginosa
610   $aliposomes
610   $aefflux pump inhibitor
610   $aPABN
610   $aaminoglycosides
610   $amacrolides
610   $apoloxamer
610   $athiourea
610   $athiolation
610   $amucoadhesion
610   $adrug release
610   $ain vivo analysis
610   $ain vitro dissolution studies
610   $aS-propargyl-cysteine
610   $apoly(lactic acid)
610   $aendogenous hydrogen sulfide
610   $awater-in-oil-in-water
610   $arheumatoid arthritis
610   $achitosan
610   $adrug delivery
610   $adrug absorption
610   $aintestinal assimilation
610   $aoral bioavailability
610   $ananoemulsions
610   $amicelles
610   $aSEDDS
610   $azeta potential
610   $asustained release
610   $aalbumin nanoparticle
610   $aMPT0B291
610   $ahigh-pressure homogenizer
610   $ahistone deacetylase
610   $acalix[8]arenes
610   $asilibinin
610   $ainclusion complexes
610   $aPEGylation
610   $acytotoxicity
610   $aoromucosal films
610   $asodium alginate
610   $ananoparticle drug carriers
610   $adigoxin
610   $azein
610   $aheart failure
610   $apolymer-liposome complexes
610   $aPluronic®-poly(acrylic acid)
610   $aPluronic®-poly(N,N-dimethylaminoethyl methacrylate)
610   $astimuli-responsive
610   $aintelligent drug delivery systems
610   $aliposome
610   $apolymer
610   $along circulation
610   $apolymer-lipid conjugates
610   $atargeting
610   $astimulus-responsive
610   $aantibody
610   $aaffinity
610   $acyclodextrin
610   $aprotein therapeutics
610   $asustained drug delivery
610   $aNitric oxide
610   $ahydrogel
610   $awound dressing
610   $achronic wounds
610   $aglycyrrhetinic acid
610   $aSoluplus®
610   $asolid dispersions
610   $aanti-inflammatory
610   $abiosafety
610   $abioavailability
615  7$aMedicine
615  7$aPharmaceutical industries
700   $aFernandes$b Ana Isabel$4edt$01331814
702   $aJozala$b Angela$4edt
702   $aFernandes$b Ana Isabel$4oth
702   $aJozala$b Angela$4oth
906   $aBOOK
912   $a9910637795003321
996   $aPolymers Enhancing Bioavailability in Drug Delivery$93040595
997   $aUNINA